What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
Early-onset Alzheimer’s disease most often begins with trouble learning or recalling recent information, while frontotemporal dementia (FTD) more often first changes behavior, personality, social judgment, language, executive skills, or movement. Those are tendencies, not diagnostic rules: Alzheimer’s can begin with non-memory problems, and memory can be affected early in FTD. Because the conditions overlap, a clinician must combine the history, an informant’s observations, cognitive and neurological examinations, laboratory tests, brain imaging, and—when appropriate—biomarkers or genetic testing.
Early-onset Alzheimer’s means Alzheimer’s developing before age 65; onset in the 30s is possible but rare. FTD is a family of disorders involving the frontal and temporal brain regions and often appears at a younger age than other dementias. If changes are interfering with work, relationships, safety, or other everyday activities, arrange an assessment with a clinician experienced in cognitive disorders rather than relying on an online symptom checklist.
What the two diagnoses mean
Dementia describes a syndrome: changes in thinking, behavior, or other abilities have become serious enough to interfere with everyday independence. Alzheimer’s disease is one disease that can cause that syndrome. FTD is a different family of disorders, not another name for dementia in general.
Free tools Windows power users keep installed
One-click scans. No signup required.
The label “early-onset” describes the age at which Alzheimer’s begins, not a separate symptom pattern. The National Institute on Aging (NIA) defines early-onset Alzheimer’s as disease developing before 65; it can start in a person’s 30s, although that is rare. FTD also tends to occur younger than many other dementias. NIA reports that roughly 60% of people with FTD are 45 to 64 years old, but that figure is not a head-to-head comparison with early-onset Alzheimer’s and should not be used to identify an individual diagnosis.
#1 Best Overall
At-a-glance comparison
| Clinical feature | Early-onset Alzheimer’s: common early pattern | FTD: common early pattern |
|---|---|---|
| Typical first problem | Learning and recalling recent information often becomes difficult first. | Behavior, personality, social conduct, communication, executive abilities, or movement may change first. |
| Memory | Recent-memory difficulty is common, but another ability can lead the presentation. | Short-term memory may be less affected at first, but memory is not guaranteed to be preserved. |
| Behavior and personality | Can change, although memory or another cognitive ability may be noticed earlier. | Disinhibition, loss of empathy, altered social judgment, apathy, or other personality changes can dominate early. |
| Language | Word-finding or other language problems can occur early. | Some forms primarily affect speech or understanding of language. |
| Executive function | Reasoning and judgment may change early in some people. | Planning, flexible thinking, impulse control, or other executive abilities may be affected early. |
| Movement | Movement changes are not usually the defining first clue, although they may occur. | Some frontotemporal disorders include movement symptoms. |
| How diagnosis is established | History, informant report, cognitive and medical evaluation, laboratory tests, imaging, and selected biomarkers. | Symptoms and examination combined with brain scans; genetic testing and other biomarkers may be useful in selected cases. |
These are patterns clinicians use to form and test a hypothesis, not a scoring system. A person can have an atypical presentation, more than one disease process, or another condition that resembles dementia.
How the first symptoms can differ
Memory and learning
In many cases of Alzheimer’s, the earliest noticeable change is difficulty taking in and retaining new information. Someone may ask the same question repeatedly, forget a recent conversation, or need more reminders for newly learned instructions. The key clinical issue is a decline from that person’s previous ability and its effect on daily functioning, not an isolated lapse.
NIA also notes that Alzheimer’s can begin with changes in language, visual-spatial ability, reasoning, or judgment. Therefore, “no obvious memory problem” does not rule out Alzheimer’s, especially when another cognitive domain is changing.
Crashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minutePC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11FTD may initially leave short-term memory relatively less affected, particularly when behavior or language is the leading problem. That is a tendency rather than a requirement. Memory can be involved early in some FTD presentations, and it can become more impaired as the disease progresses.
Behavior, personality, and social judgment
Early behavioral-variant FTD can look like a change in the person’s character rather than a memory disorder. Families may notice inappropriate comments, impulsive decisions, loss of social tact, reduced empathy, rigid or repetitive routines, unusual eating behavior, or marked apathy. The person may not recognize the change, while relatives or colleagues see a sustained departure from long-standing behavior.
Behavior and judgment can also change in Alzheimer’s. The distinction is the overall pattern and sequence: in FTD, social conduct, motivation, or personality may be the most prominent initial problem; in Alzheimer’s, those changes may accompany or follow more recognizable learning and memory difficulties. A clinician needs examples from someone who knows the person well.
Speech and language
Both conditions can affect communication. Alzheimer’s may cause word-finding pauses, trouble following a conversation, or difficulty expressing a thought, sometimes early in the illness. FTD includes language-led syndromes in which speaking, understanding words, naming objects, grammar, or the meaning of language deteriorates before other abilities.
Describe the exact change rather than simply reporting “language trouble.” Losing the meaning of familiar words, producing increasingly effortful speech, or speaking less while social behavior remains stable points to a different clinical pattern than forgetting names because new information is not being retained. Only formal assessment can determine which abilities are affected.
Executive abilities and everyday tasks
Executive abilities include organizing, sequencing, switching between tasks, evaluating consequences, and inhibiting impulses. Alzheimer’s can affect reasoning and judgment early, and a person may struggle with finances, navigation, or multistep work even when the family initially focuses on memory.
FTD often disrupts executive control early. A person may fail to plan a familiar task, persist with an ineffective approach, act without considering consequences, or lose the ability to adapt to routine changes. Daily-task difficulties should be described in concrete terms: what the person used to do independently, what now goes wrong, and whether the problem is forgetting, disorganization, language, motivation, or unsafe judgment.
Movement
Some frontotemporal disorders include movement symptoms, so a neurological examination matters even when the initial complaint is behavioral or linguistic. Alzheimer’s can also eventually affect movement, but movement findings alone do not identify either diagnosis. Clinicians consider the timing, type, and combination of motor and cognitive changes.
Quick wins for a faster PC:
Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Repair Windows errors before they cause bigger problemsFix Now →Why FTD can be mistaken for Alzheimer’s
Symptoms overlap across the two disease families. A person with FTD may have memory difficulties, while a person with Alzheimer’s may first show language, visual-spatial, reasoning, or behavioral changes. Depression, medication effects, sleep problems, other neurological diseases, and medical conditions can also produce cognitive or behavioral symptoms, which is why the evaluation includes tests for alternative causes.
Brain pathology can overlap as well. Some frontotemporal presentations can include beta-amyloid plaques associated with Alzheimer’s. Conversely, finding amyloid does not automatically establish that Alzheimer’s is causing the current symptoms. A biomarker result must be interpreted alongside the history, examination, cognitive profile, and imaging.
For these reasons, age is a clue but never a diagnosis. Being under 65 makes early-onset Alzheimer’s possible and FTD epidemiologically relevant, but it does not distinguish them by itself.
How clinicians diagnose the cause
Diagnosis is a staged clinical process rather than a single screening score or scan. The exact combination depends on the symptoms, medical history, examination findings, availability of specialist services, and the questions the clinician needs to answer.
- Build a timeline with the person and an informant. The clinician asks when the change began, how it has progressed, and which abilities changed first. A spouse, relative, friend, or colleague can provide observations the affected person does not notice. The interview covers health conditions, medicines and substances, sleep, mood, daily function, behavior, personality, work performance, and safety.
- Test cognitive abilities. Office-based or more extensive neuropsychological testing can examine memory, learning, problem solving, attention, counting, language, and other abilities. The pattern—what is impaired and what remains strong—often provides more information than a single total score.
- Look for other, potentially treatable causes. Standard blood and urine tests can identify medical problems that mimic or worsen cognitive symptoms. Reviewing medicines and conducting a psychiatric assessment may reveal contributors such as medication effects, depression, or another mental-health condition. A normal basic test does not prove Alzheimer’s or FTD; it narrows the alternatives.
- Perform a neurological and physical examination. Clinicians assess movement, strength, coordination, reflexes, speech, sensory findings, and other signs that could support a particular neurological diagnosis or point elsewhere.
- Use brain imaging when indicated. CT or MRI can show structural changes, strokes, tumors, hydrocephalus, or patterns of atrophy. PET imaging can provide information about brain metabolism or particular proteins in settings where it is appropriate. Imaging is interpreted with the clinical picture; it is not a stand-alone verdict.
- Add cerebrospinal-fluid or other biomarker testing selectively. Cerebrospinal-fluid (CSF) protein tests and other biomarkers may help evaluate Alzheimer’s-related pathology or distinguish competing explanations. Availability varies, and some tests are limited to specialty clinics or research settings. The NIA explains how biomarkers can support, but not replace, clinical diagnosis at its biomarker guidance.
- Consider genetic testing when the history or presentation warrants it. For FTD, clinicians may use genetic tests together with symptoms and scans, particularly when there is a strong family history or an early, suggestive presentation. Genetic testing has implications for relatives and should be discussed with an appropriately trained professional; it is not necessary for everyone with suspected FTD.
- Integrate the evidence and follow the course. The clinician weighs the timeline, informant report, cognitive profile, examination, laboratory results, imaging, and any biomarkers. If the pattern remains uncertain, follow-up can show how abilities change and whether the working diagnosis needs revision.
NIA’s overview of Alzheimer’s diagnosis describes interviews, cognitive testing, laboratory work, psychiatric assessment, CSF testing, and CT, MRI, or PET imaging as tools that may be used; not every person needs every test. Its detailed explanation is available at How Is Alzheimer’s Disease Diagnosed?
What scans and biomarkers can—and cannot—tell you
Structural and functional imaging
CT and MRI can exclude or identify other structural problems and may show patterns of brain atrophy that support a clinician’s assessment. PET techniques can examine metabolism or specific protein deposits. A scan is evidence within a diagnostic argument, not a label that can be read without context. Normal-looking images do not automatically exclude disease, and an abnormality does not by itself establish which process is responsible for symptoms.
Amyloid and other protein biomarkers
Some tests detect beta-amyloid or other proteins associated with neurodegenerative disease. A positive amyloid scan indicates amyloid pathology, but it does not prove that Alzheimer’s is the sole or primary cause of the person’s present symptoms. Amyloid can coexist with FTD or another disorder. Clinicians therefore interpret the result in relation to the symptom pattern, examination, cognitive testing, and imaging.
Why access and timing matter
Biomarker testing is not uniformly available, and clinicians may reserve it for cases in which the result will change management or clarify a difficult diagnosis. Results can also be affected by the test’s technical characteristics and the clinical setting. Ask what question the test is intended to answer, how a positive or negative result would change the diagnosis, and whether follow-up counseling is provided.
Practical clues to document before an appointment
A concise timeline helps a specialist distinguish a gradual neurodegenerative pattern from a fluctuating or potentially reversible problem. Keep observations factual and dated rather than assigning a diagnosis.
- Write down the first change noticed and the month or year it began.
- Record specific examples of repeated questions, missed appointments, lost skills, language errors, altered eating, impulsive behavior, apathy, or trouble planning.
- Note whether the person recognizes the problem and how much help is needed with finances, medicines, driving, cooking, work, or personal care.
- List all prescription medicines, over-the-counter products, supplements, alcohol or other substances, and recent changes.
- Bring information about sleep, mood, major medical illnesses, head injuries, seizures, and family history of dementia or neurological disease.
- Ask a trusted informant to attend or provide a written account, because insight can be reduced in both Alzheimer’s and FTD.
These notes are not a home diagnostic test. They give the clinician a reliable baseline and reduce the chance that a brief appointment will miss the order or context of the changes.
Common assumptions that lead people astray
“It is under 65, so it must be FTD.”
FTD is common in younger adults relative to many other dementias, but early-onset Alzheimer’s also occurs before 65. NIA’s estimate that roughly 60% of people with FTD are 45 to 64 describes the age distribution within FTD, not the probability that any particular younger adult has FTD.
“Memory is normal, so it cannot be Alzheimer’s.”
Alzheimer’s can begin with language, visual-spatial, reasoning, or judgment changes. A clinician evaluates the complete cognitive profile rather than using memory as a yes-or-no gate.
The Tool Desk
Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →“FTD always spares memory.”
Short-term memory may be less affected initially in some FTD forms, but memory problems can occur early and can emerge later. The relative prominence and sequence of symptoms matter more than an absolute rule.
“One scan proves the diagnosis.”
Imaging and biomarkers add evidence but do not replace history and examination. In particular, a positive amyloid result alone does not establish that Alzheimer’s pathology explains the current symptoms.
“Dementia and Alzheimer’s are interchangeable.”
Dementia is the functional syndrome; Alzheimer’s is one cause, and FTD is another family of causes. Using the terms precisely helps families understand why a clinician is considering several diagnoses.
When to seek an evaluation
Arrange a clinical assessment when cognitive, behavioral, language, or movement changes persist, progress, or interfere with everyday independence. Early evaluation can identify treatable contributors, document a baseline, clarify whether the pattern is more consistent with Alzheimer’s, FTD, another condition, or mixed pathology, and guide planning. A primary-care clinician can begin the work-up and refer to a neurologist, geriatrician, neuropsychologist, or memory-disorders clinic as needed.
Do not wait for a dramatic memory failure if the main change is unsafe judgment, a striking personality shift, loss of language, or inability to organize familiar tasks. Those symptoms are clinically important even when recall seems relatively intact.
Bottom line for families
Early-onset Alzheimer’s commonly starts with impaired learning and recall of recent information; FTD more often starts with behavior, personality, social-emotional responses, language, executive function, or movement changes. Neither pattern is absolute, and the two conditions can overlap in symptoms and brain pathology. A reliable diagnosis comes from a clinician who combines a detailed timeline and informant report with cognitive and neurological examinations, laboratory testing, imaging, and selected CSF, other biomarker, or genetic tests. Age and symptom lists can indicate what to investigate, but they cannot diagnose the disease at home.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
